Updated:
Apothems
Apothems is an Italian asset manager executing venture and co-investment mandates under OAN Capital control.
Apothems
Apothems is a venture capital investment company based in Italy. It focuses on venture capital investments.
General information
Firm type
Generalist
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Italy
City
—
Corporate office
Italy
Principals
Gianluca Settepani
Founder
Sector focus
Frequently asked questions
Who controls Apothems?
OAN Capital S.r.l. controls Apothems S.à r.l. as its Italian merchant bank and holding entity. Rowrow S.à r.l. acts as co-owner.
What investment strategies does Apothems follow?
Apothems pursues co-investments and general venture opportunities. It has participated in healthcare-related vehicles alongside Enpam.
Which named individuals have held roles at Apothems?
Gianluca Settepani is the founder. Ronny Hashmonay served as a former board member with a healthcare industry background.
Where does Apothems hold real estate exposure?
Apothems holds the Antirion Global Comparto Hotel commercial asset with locations in Milan, Italy and Paris, France.
How is Apothems connected to Xyence?
Gianluca Settepani played a key role in the acquisition of Principia SGR, which became Xyence, and Enpam invests in Xyence Capital funds.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: